FibroGen, Inc. (FGEN) — Financial statements
Income statement, balance sheet, and cash flow for FibroGen, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 6↓78.3% | 30↓36.7% | 47↓66.7% | 141↓40.2% | 235 | |
| Cost of Revenue | 0.00↓100.0% | 16↑292.8% | 4↓80.5% | 20↓95.5% | 449 | |
| Gross Profit | 0.00↓100.0% | 14↓67.2% | 43↓64.4% | 120↑156.3% | -214 | |
| Operating Expenses | ||||||
| R&D Expenses | 24↓75.4% | 96↓64.1% | 266↓10.2% | 297↓23.3% | 387 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 28↓43.8% | 49↓43.0% | 86↓30.6% | 125 | 0.00 | |
| Other Expenses | 0.00↓100.0% | 19↑54.3% | 13 | 0.00↑100.0% | -312 | |
| Operating Expenses | 51↓68.9% | 164↓55.0% | 366↓13.3% | 421↑464.6% | 75 | |
| Total Costs & Expenses | 52↓70.9% | 180↓51.3% | 370↓16.4% | 442↓15.7% | 524 | |
| Operating Results | ||||||
| Operating Income | -46↑69.5% | -150↑53.4% | -323↓7.2% | -301↓4.3% | -289 | |
| Depreciation & Amortization | 0.75↓72.2% | 3↓72.9% | 10↓6.4% | 11↓28.4% | 15 | |
| EBITDA | -46↑67.8% | -142↑53.3% | -305↓7.9% | -283↑15.3% | -334 | |
| EBIT | 0.00↑100.0% | -145↑53.9% | -315↓7.4% | -293↑15.8% | -349 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -3↓489.0% | -0.50↓108.1% | 6↑672.7% | -1 | |
| Interest Income | 0.00↓100.0% | 5↓30.3% | 8↓0.0% | 8 | — | |
| Interest Expense | -9↓206.2% | 8↑1.9% | 8↑462.2% | 1↑34.0% | 1 | |
| Non-Operating Income | 0.00↑100.0% | -5↑30.3% | -8↑0.0% | -8↓112.7% | 60 | |
| Other Income / Expenses | -12↓320.2% | -3↓489.0% | -0.50↓106.5% | 8↑774.4% | -1 | |
| Income Before Tax | -58↑62.0% | -153↑52.6% | -323↓10.2% | -293↓1.2% | -290 | |
| Income Tax Expense | -0.09↑66.5% | -0.27↓6.7% | -0.25↓170.4% | 0.36↑3.2% | 0.35 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 183↑219.8% | -153↑52.6% | -323↓10.0% | -294↓1.3% | -290 | |
| Net Income from Discontinued Operations | 0.00↓100.0% | 106↑172.4% | 39 | 0.00 | 0.00 | |
| Net Income | 183↑485.6% | -48↑83.3% | -284↑3.2% | -294↓1.3% | -290 | |
| Bottom-Line Net Income | 183↑485.6% | -48↑83.3% | -284↑3.2% | -294↓1.3% | -290 | |
| EPS (Basic) | 45.37↑9552.1% | -0.48↑83.6% | -2.92↑7.3% | -3.15↑0.0% | -3.15 | |
| EPS (Diluted) | 45.37↑9552.1% | -0.48↑83.6% | -2.92↑7.3% | -3.15↑0.0% | -3.15 | |
| Weighted Average Shares | 4↓96.0% | 100↑2.8% | 97↑4.0% | 94↑1.3% | 92 | |
| Weighted Average Diluted Shares | 4↓96.0% | 100↑2.8% | 97↑4.0% | 94↑1.3% | 92 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.